Recent research progress in construction of biomimetic engineered cardiac tissue based on extracellular matrix / 中国组织工程研究

BACKGROUND: Patches, powders and hydrogels fabricated from extracellular matrix and its components can be used as scaffolds, along with a variety of stem cells and their derivatives, to construct biomimetic engineered cardiac tissue. OBJECTIVE: To review research progress in construction of biomimetic engineered cardiac tissue based on extracellular matrix. METHODS: We searched the articles in Web of Science Core Collection and PubMed databases with the key words of “the extracellular matrix; engineered cardiac tissue; cardiomyocyte; biomimetic; stem cell” in English. Eventually 64 articles were included for review. RESULTS AND CONCLUSION: Compared with the traditional synthetic materials, the extracellular matrix has good biocompatibility and cell affinity, which can provide seed cells with the closest living environment, and is conducive to the growth, differentiation and maturation of seed cells. A great number of research evidences suggest that the biomimetic engineered cardiac tissue based on extracellular matrix and stem cells has the characteristics of excitability, contractility and conductivity similar to the natural myocardial tissue. It also can repair the damaged myocardium, reshape the microvascular system and effectively improve cardiac function, showing the potential to treat cardiovascular diseases such as myocardial infarction. However, there are still some problems in the construction of biomimetic engineered cardiac tissue based on extracellular matrix, such as the structural damage during decellularization, the relatively slow development of seed cell morphology and function.

Detection of HBVDNA and HBVcccDNA in Peripheral Blood Mononuclear Cells by a Multiplex Polymerase Chain Reaction / 中国医师杂志

Objective To establish a multiplex polymerase chain reaction (M-PCR) assay to detect HBV DNA in the peripheral blood mononuclear cells(PBMCs) of chronic HB patients. Methods One pair of primer amplifying HBV genome DNA and another pair of primer amplifying HBV covalently closed circular DNA (cccDNA ) were added to one PCR reaction to detect HBV DNA in PBMCs. Results Various forms of HBVDNA including total DNA and cccDNA could be amplified simultaneously. Among the 30 chronic HB patients, both the HBVDNA and HBVcccDNA in the PBMCs of 23 patients were detected, the positive rate of which was 76.6%. The positive rate of HBV cccDNA accounted for 82.1% of total HBV DNA positive rate. Conclusion HBVDNA in the PBMCs could partially replicate. The M-PCR was successfully set up to amplify HBV genome DNA and HBV cccDNA simultaneously.